Cargando…
Efficacy of Cyproheptadine Monotherapy in Hepatocellular Carcinoma With Bone Metastasis: A Case Report
BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common causes of cancer-related deaths worldwide. Particularly, cases of bone metastasis have poorer prognoses. CASE PRESENTATION: A 62-year-old woman with suspected advanced HCC accompanied by bone metastasis with severe back pain and sc...
Autores principales: | Feng, Yu-Min, Chen, Tsung-Hsien, Berman, Dara, Chou, Chu-Kuang, Liao, Kai-Sheng, Hsieh, Ming-Chih, Chen, Chi-Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563693/ https://www.ncbi.nlm.nih.gov/pubmed/34745929 http://dx.doi.org/10.3389/fonc.2021.620212 |
Ejemplares similares
-
Cyproheptadine-Induced Acute Liver Failure
por: Chertoff, Jason, et al.
Publicado: (2014) -
Hyperthermia and Serotonin: The Quest for a “Better Cyproheptadine”
por: Petroianu, Georg A.
Publicado: (2022) -
Cyproheptadine significantly improves the overall and progression-free survival of sorafenib-treated advanced HCC patients
por: Feng, Yu-Min, et al.
Publicado: (2015) -
Cyproheptadine, an antihistaminic drug, inhibits proliferation of hepatocellular carcinoma cells by blocking cell cycle progression through the activation of P38 MAP kinase
por: Feng, Yu-Min, et al.
Publicado: (2015) -
Emerging Perspectives of Bone Metastasis in Hepatocellular Carcinoma
por: Yuan, Xiaofeng, et al.
Publicado: (2022)